Posted by Sarita Garza on Sep 14th, 2024
Relmada Therapeutics, Inc. (NASDAQ:RLMD – Get Free Report) CEO Sergio Traversa acquired 51,407 shares of the stock in a transaction dated Wednesday, September 11th. The stock was acquired at an average price of $2.99 per share,...
More of this article »